60 Degrees Pharmaceuticals SXTP
NASDAQ SXTP
$1.33 +0.08 (+6.40%)
At close: Sep 30, 2026 · 4:00 PM EDT

60 Degrees Pharmaceuticals (SXTP) Debt Ratio (2022 - 2025)

Updated

60 Degrees Pharmaceuticals' (SXTP) Debt Ratio stood at 0.03 in Q4 2025, up 5.2% from 0.03 a year earlier.

Analysis

60 Degrees Pharmaceuticals (SXTP) Debt Ratio (2022 - 2025) Analysis & Trends

Starting with Q4 2022, 60 Degrees Pharmaceuticals' Debt Ratio history includes 6 quarters.

  • Across earlier years, Debt Ratio came in at 0.03 in FY2024, 0.00 in FY2023 (-100.0%) and 17.15 in FY2022.
  • The Q4 2025 figure is the highest quarterly Debt Ratio since Q2 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 0.24
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 0.52
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 0.42
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 0.31
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 0.00
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 0.60
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 0.53
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 0.31
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn -
10 60 Degrees Pharmaceuticals 3.32 Mn 2.22 Mn 56,798.00 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 0.03
Dec 31, 2024 0.03
Mar 31, 2024 0.00
Dec 31, 2023 0.00
Jun 30, 2023 3.51
Dec 31, 2022 17.15
API Access

60 Degrees Pharmaceuticals Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=SXTP&period=max&api_key=YOUR_API_KEY